Welcome to our dedicated page for Omada Health SEC filings (Ticker: OMDA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Omada Health, Inc. (Nasdaq: OMDA) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. As a virtual-first, between-visit healthcare provider focused on cardiometabolic and musculoskeletal conditions, Omada uses these filings to report on its financial condition, operations, and material events related to its digital chronic care platform.
Investors can review current reports on Form 8-K, which Omada uses to furnish press releases announcing quarterly results and other significant developments. For example, recent 8-K filings reference earnings press releases for periods in which the company reported revenue, member growth, and updates on its GLP-1-related offerings and AI capabilities. These current reports help readers connect headline financial and operational metrics to the underlying SEC record.
In addition to 8-Ks, Omada’s periodic reports on Form 10-Q and Form 10-K (accessible through the SEC and linked from this page when available) typically contain more detailed information on revenue composition, cost structure, research and development spending, and risks associated with its virtual care and GLP-1 programs. These filings are particularly relevant for understanding how Omada’s cardiometabolic and musculoskeletal programs, GLP-1 Care Tracks, and prescribing and medication management capabilities are reflected in its financial statements and risk disclosures.
Stock Titan enhances this information with AI-powered summaries that explain key points from lengthy filings, helping readers quickly identify sections related to Omada’s chronic care model, GLP-1 initiatives, and digital health operations. Users can also monitor updates to OMDA’s filings in near real time, including new 8-Ks, 10-Qs, 10-Ks, and other relevant forms, to follow how the company reports on its performance and material events over time.
An affiliate of OMDA filed to potentially sell 12,944 shares of common stock through Morgan Stanley Smith Barney’s Executive Financial Services, following an exercise of stock options for cash on 08/03/2026, with sales expected on NASDAQ. The filing also lists several prior Rule 10b5-1 sales by Sean Duffy over the past three months, each specifying trade dates, share amounts, and dollar proceeds.
HILLEMAN JERYL L reported acquisition or exercise transactions in this Form 4 filing.
Omada Health, Inc. director Jeryl L. Hilleman received a grant of 1,435 restricted stock units of Common Stock on July 5, 2026 under the company’s Non-Employee Director Compensation Program in lieu of cash retainer fees. Each RSU represents one share, increasing her directly held beneficial ownership to 26,655 shares. This Form 4/A amends an earlier report that had understated both the RSU grant and resulting holdings due to an administrative error.
Omada Health, Inc. Chief Financial Officer Steven L. Cook exercised stock options for 12,150 shares of Common Stock at an exercise price of $8.28 per share, then sold 12,150 shares in open-market transactions at $24.0148 and $24.00 per share pursuant to a Rule 10b5-1 trading plan. Following these trades, he directly owned 187,209 shares of Common Stock.
Omada Health, Inc.'s Chief Accounting Officer, Gracey Craig, exercised stock options to acquire 1,041 shares of common stock at $6.57 per share and, on the same date, sold 1,041 shares in an open-market transaction at $24.00 per share pursuant to a 10b5-1 trading plan. Following these transactions, she holds 15,441 common shares directly and 33,334 stock options that remain outstanding.
Omada Health, Inc. Chief Financial Officer Steven L. Cook reported an exercise-and-sell transaction dated July 13, 2026. He exercised options for 5,800 common shares at $8.2800 per share and sold 5,800 common shares in open-market trades at $24.0100 and $24.0000 per share under a 10b5-1 trading plan, leaving 193,009 common shares held directly.
Steven Cook plans to sell 12,150 shares of OMDA common stock through Morgan Stanley Smith Barney LLC on NASDAQ around 07/15/2026. These shares are listed as acquired from the issuer via an exercise of stock options for cash on the same date. Over the past three months, Cook has already completed multiple 10b5-1 sales of OMDA common shares, with individual transactions ranging from 300 shares to 33,000 shares and reported dollar amounts reaching into the hundreds of thousands of dollars per trade.
Craig Gracey filed a notice to sell OMDA common stock through Morgan Stanley Smith Barney LLC’s Executive Financial Services. The filing covers 1,041 common shares, tied to an Exercise of Stock Options for cash, with a proposed sale date of 07/13/2026.
The filing also lists recent 10b5-1 Sales of OMDA common shares by Gracey, including transactions on 06/12/2026, 06/22/2026, 06/24/2026, 06/26/2026, 06/29/2026, 06/30/2026, and 07/01/2026, each specifying shares sold and total proceeds.
A holder of OMDA common stock, working through Morgan Stanley Smith Barney LLC Executive Financial Services, has filed a notice to sell up to 5,800 shares of common stock on July 13, 2026. The shares are tied to the exercise of stock options for cash, with an indicated aggregate value of $135,024.00.
The notice also lists prior OMDA common stock sales for Steven Cook over the past three months labeled as 10b5-1 Sales, including 33,000 shares for $656,450.84 on June 26, 2026 and 23,263 shares for $529,500.01 on July 1, 2026, along with several additional smaller transactions.
Omada Health, Inc.’s Chief Executive Officer Sean P. Duffy reported an amended insider transaction showing a series of same-day option exercises and open-market sales of common stock. Over June 24–26, 2026, he exercised options for 17,258 shares and sold 17,258 shares at prices around the high‑$19 to $20.90 range in pre-planned trades under a Rule 10b5-1 trading plan.
The amendment corrects the original Form 4 by adding the omitted exercise entries and adjusting the number of securities beneficially owned after the transactions. Following these sales, Duffy directly held 411,861 shares of Omada Health common stock, while family trusts held 851,659 additional shares for the benefit of his family members, for which he disclaims beneficial ownership except for his pecuniary interest.
Omada Health, Inc. Chief Accounting Officer Craig Gracey executed routine same-day option exercise-and-sale transactions and corrected prior reporting. On June 26, 2026 and June 29, 2026, Gracey exercised stock options at an exercise price of $6.57 per share and sold the resulting common shares in open-market transactions at prices of $20.00 and $21.00 per share. Following these transactions, Gracey directly beneficially owned 15,441 shares of common stock. The amended Form 4 restates an earlier filing to add the previously omitted option exercises and adjusts the reported beneficial ownership. The transactions were made under a Rule 10b5-1 trading plan adopted on March 13, 2026.